| abstract |
The present invention relates to novel stilbene-like compounds represented by general formula (I), derivatives, analogs, tautomers, stereoisomers, polymorphs, hydrates, metabolites, prodrugs, and solvates. Pharmaceutically acceptable salts and compositions thereof are provided. These compounds can inhibit HDAC and are useful as therapeutic or ameliorating agents for diseases associated with cell proliferation such as malignant tumors, autoimmune diseases, skin diseases, infections, and inflammation. |